academic article

• Examining the effects of race/ethnicity and other factors on outcomes of care for complex regional pain syndrome type 1 in the United States..  PLOS global public health.  5:-. 2025
• Impact of Anticholinergic Burden and Clinical-Demographic Characteristics on Incident Dementia in Parkinson Disease..  Journal of geriatric psychiatry and neurology.  -. 2025
• Defining key deprescribing measures from electronic health data: A multisite data harmonization project..  Journal of the American Geriatrics Society.  2024
• End-of-Life Health Care Service Use and Cost Among Medicare Decedents With Neurodegenerative Diseases..  Neurology.  103:-. 2024
• Attitudes and beliefs towards medication burden and deprescribing in Parkinson disease..  BMC neurology.  24:-. 2024
• Application of High-Dimensional Propensity Score Methods to the National Health and Aging Trends Study..  The journals of gerontology. Series A, Biological sciences and medical sciences.  79. 2024
• Long-Term Dementia Risk in Parkinson Disease..  Neurology.  103:-. 2024
• Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events..  JAMA neurology.  81:835-844. 2024
• Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease..  Brain sciences.  14. 2024
• Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease: The FIRE-UP PD study..  Contemporary clinical trials.  -. 2024
• Interaction between visual impairment and genetic risk of dementia and psychosis in older adults..  Age and ageing.  53. 2024
• Thinking Three-Dimensionally: A Self- and Externally-Controlled Approach to Screening for Drug-Drug-Drug Interactions Among High-Risk Populations..  Clinical pharmacology and therapeutics.  116:448-459. 2024
• Self-reported Visual Difficulty, Age-related Eye Disease, and Neuropsychiatric Outcomes in Older Adults..  Ophthalmic epidemiology.  1-9. 2024
• Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide level..  NPJ Parkinson's disease.  10:-. 2024
• Nationwide emergency department visits for pediatric traumatic spinal cord injury in the United States, 2016-2020..  Frontiers in neurology.  -. 2023
• Unique characteristics of end-of-life hospitalizations in Parkinson disease..  Frontiers in aging neuroscience.  -. 2023
• Health equity integrated epilepsy care and research: A narrative review..  Epilepsia.  64:2878-2890. 2023
• Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease..  Parkinsonism & Related Disorders.  -. 2023
• Potentially inappropriate medications in older adults with Parkinson disease before and after hospitalization for injury..  Parkinsonism & Related Disorders.  -. 2023
• Care access and utilization among medicare beneficiaries living with Parkinson's disease..  NPJ Parkinson's disease.  9:-. 2023
• The Water, the Air, the Marines-Camp Lejeune, Trichloroethylene, and Parkinson Disease..  JAMA neurology.  80:663-665. 2023
• Adjusting for Underrepresentation Reveals Widespread Underestimation of Parkinson's Disease Symptom Burden..  Movement disorders : official journal of the Movement Disorder Society.  38:1679-1687. 2023
• Sociodemographic and Geographic Disparities in End-of-Life Health Care Intensity Among Medicare Beneficiaries With Parkinson Disease..  Neurology Clinical Practice.  13:-. 2023
• Racial and Ethnic Disparities in Parkinson Disease: A Call to Action..  Neurology Clinical Practice.  13:-. 2023
• Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies..  Neurotherapeutics.  20:375-388. 2023
• Dopamine agonists and risk of lung cancer in patients with restless legs syndrome..  Pharmacoepidemiology and Drug Safety.  32:726-734. 2023
• Functional Impairment in Individuals With Prodromal or Unrecognized Parkinson Disease..  JAMA neurology.  80:200-204. 2023
• Seasonal Variation in Neurologic Hospitalizations in the United States..  Annals of Neurology.  93:743-751. 2022
• Interfacility Transfers for Seizure-Related Emergencies in the United States..  Neurology.  99:e2718-e2727. 2022
• Hallucinations, Antipsychotic Use, and Mortality in Older Adults with Dementia: Retrospective Cohort Study of Two Medicare-Linked National Health Surveys..  Drugs & aging.  39:967-974. 2022
• Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies..  Pharmacoepidemiology and drug safety.  32:9-18. 2022
• Amphetamine-related care in the USA, 2003-2014: cross-sectional analyses examining inpatient trends and factors associated with hospitalisation outcomes..  BMJ open.  12:-. 2022
• Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's disease..  Clinical Autonomic Research.  32:463-476. 2022
• Atypical antipsychotic use and mortality risk in Parkinson disease..  Parkinsonism & related disorders.  17-22. 2022
• Nationwide trends in emergency department utilisation for acute retinal ischaemia in the USA, 2011-2018..  The British journal of ophthalmology.  107:1490-1495. 2022
• Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals..  Frontiers in pharmacology.  -. 2022
• Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study..  Contemporary clinical trials.  -. 2022
• Population-Based Study of Nonelective Postpartum Readmissions in Women With Stroke, Migraine, Multiple Sclerosis, and Myasthenia Gravis..  Neurology.  98:e1545-e1554. 2022
• Comparative risk of serious hypoglycemia among persons dispensed a fluoroquinolone versus a non-fluoroquinolone antibiotic..  Diabetes research and clinical practice.  -. 2022
• Pediatric Traumatic Spinal Cord Injury in the United States: A National Inpatient Analysis..  Topics in spinal cord injury rehabilitation.  28:1-12. 2022
• Geographic Barriers Drive Disparities in Specialty Center Access for Older Adults with Huntington's Disease..  Journal of Huntington's disease.  11:81-89. 2022
• Incidence of Parkinson disease in North America.  npj Parkinson's Disease.  2022
• Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users..  Pharmacoepidemiology and Drug Safety.  31:393-403. 2021
• Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?.  Movement disorders clinical practice.  8:1181-1188. 2021
• ICD-10.  Neurology. Clinical practice.  11:e612-e619. 2021
• Statins for the Prevention of Post-Stroke Seizure and Epilepsy Development: A Systematic Review and Meta-Analysis..  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.  30:-. 2021
• Medicare Claims Data Underestimate Hallucinations in Older Adults With Dementia..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  30:352-359. 2021
• Strengthened through Diversity: A Blueprint for Organizational Change..  Annals of Neurology.  90:524-536. 2021
• Low continuation of antipsychotic therapy in Parkinson disease - intolerance, ineffectiveness, or inertia?.  BMC neurology.  21:-. 2021
• Readmission Following Hospitalization for Traumatic Brain Injury: A Nationwide Study..  The Journal of head trauma rehabilitation.  37:E165-E174. 2021
• Prevalence and Risk Factors for Double Vision in Parkinson Disease..  Movement disorders clinical practice.  8:709-712. 2021
• Multiple sclerosis hospitalizations among users of oral disease-modifying therapies..  Multiple sclerosis and related disorders.  -. 2021
• Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis..  Muscle & nerve.  64:156-162. 2021
• Claims-Based Frailty and Outcomes: Applying an Aging Measure to Older Adults with Parkinson's Disease..  Movement disorders : official journal of the Movement Disorder Society.  36:1871-1878. 2021
• Comparative neurological safety of fluoroquinolones versus therapeutic alternatives..  Pharmacoepidemiology and Drug Safety.  30:797-805. 2021
• A nationwide analysis of maternal morbidity and acute postpartum readmissions in women with epilepsy..  Epilepsy & behavior : E&B.  -. 2021
• Neurodegenerative disease is associated with increased incidence of epilepsy: a population based study of older adults..  Age and ageing.  50:205-212. 2021
• Clinical and Economic Outcomes Associated with Dysphagia in Hospitalized Patients with Parkinson's Disease..  Journal of Parkinson's disease.  11:1965-1971. 2021
• Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study..  Journal of Parkinson's disease.  11:757-765. 2021
• Inconsistent reporting of drug-drug interactions for hormonal contraception and antiepileptic drugs - Implications for reproductive health for women with epilepsy..  Epilepsy & behavior : E&B.  114:-. 2020
• Trends in the Surgical Treatment of Pseudotumor Cerebri Syndrome in the United States..  JAMA network open.  3:-. 2020
• Trends in oral anticoagulant co-prescription with antiepileptic drugs among adults with epilepsy, 2010-2018..  Epilepsy & behavior : E&B.  -. 2020
• Predictors of Mortality in Older Adults With Epilepsy: Implications for Learning Health Systems..  Neurology.  96:e93-e101. 2020
• Impact of Hospitalization and Medication Switching on Post-discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation..  Pharmacotherapy.  40:1022-1035. 2020
• Survival and Health Care Use After Deep Brain Stimulation for Parkinson's Disease..  The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques.  48:372-382. 2020
• Frequency of and risk factors for potentially inappropriate medication use in Parkinson's disease..  Age and ageing.  49:786-792. 2020
• Self-reported vision and hallucinations in older adults: results from two longitudinal US health surveys..  Age and ageing.  49:843-849. 2020
• Visual Impairment Is More Common in Parkinson's Disease and Is a Risk Factor for Poor Health Outcomes..  Movement disorders : official journal of the Movement Disorder Society.  35:1542-1549. 2020
• Comorbid disease drives short-term hospitalization outcomes in patients with multiple sclerosis..  Neurology. Clinical practice.  10:255-264. 2020
• Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  29:35-47. 2020
• Disparities in Deep Brain Stimulation Use for Parkinson's Disease in Ontario, Canada..  The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques.  47:642-655. 2020
• Unplanned Readmissions of Children With Epilepsy in the United States..  Pediatric Neurology.  93-98. 2020
• Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis..  Clinical parkinsonism & related disorders.  -. 2020
• A contemporary analysis of goiters undergoing surgery in the United States..  American journal of surgery.  220:341-348. 2020
• Parkinson Disease Associated Differences in Elective Orthopedic Surgery Outcomes: A National Readmissions Database Analysis..  Journal of Parkinson's disease.  10:1577-1586. 2020
• Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis..  Parkinsonism & related disorders.  96-102. 2019
• Readmissions after hospital care for meningitis in the United States..  American journal of infection control.  48:798-804. 2019
• Poor concordance among drug compendia for proposed interactions between enzyme-inducing antiepileptic drugs and direct oral anticoagulants..  Pharmacoepidemiology and drug safety.  28:1534-1538. 2019
• Blindness and Visual Impairment in the Medicare Population: Disparities and Association with Hip Fracture and Neuropsychiatric Outcomes..  Ophthalmic epidemiology.  26:279-285. 2019
• Readmission after seizure discharge in a nationally representative sample..  Neurology.  92:e429-e442. 2019
• State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease..  NPJ Parkinson's disease.  -. 2019
• Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease..  JAMA Neurology.  76:41-49. 2019
• Adverse Drug Events as a Reason for Adult Hospitalization: A Nationwide Readmission Study..  Annals of Pharmacotherapy.  53:557-566. 2018
• Understanding nationwide readmissions after thyroid surgery..  Surgery.  165:423-430. 2018
• Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients..  Neurology.  92:e9-e18. 2018
• Association between medication-related adverse events and non-elective readmission in acute ischemic stroke..  BMC neurology.  18:-. 2018
• β2-adrenoreceptor medications and risk of Parkinson disease..  Annals of Neurology.  84:683-693. 2018
• Inpatient care for stiff person syndrome in the United States: a nationwide readmission study..  Journal of clinical movement disorders.  -. 2018
• Readmissions After Mechanical Thrombectomy for Acute Ischemic Stroke in the United States: A Nationwide Analysis..  Journal of Stroke and Cerebrovascular Diseases.  27:2632-2640. 2018
• Immunosuppressants and risk of Parkinson disease..  Annals of Clinical and Translational Neurology.  5:870-875. 2018
• Sociodemographic Factors Associated With Hospital Care for Pediatric Migraine: A National Study Using the Kids' Inpatient Dataset..  Pediatric Neurology.  34-40. 2018
• Telemedicine for Parkinson's Disease: Limited Engagement Between Local Clinicians and Remote Specialists..  Telemedicine and e-Health.  24:722-724. 2018
• Using Medical Claims Analyses to Understand Interventions for Parkinson Patients..  Journal of Parkinson's Disease.  8:45-58. 2018
• Sex disparities in health and health care utilization after Parkinson diagnosis: Rethinking PD associated disability..  Parkinsonism & related disorders.  45-50. 2017
• Sex disparities in access to caregiving in Parkinson disease..  Neurology.  90:e48-e54. 2017
• Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study..  Movement Disorders.  32:1636-1640. 2017
• Hospitalizations of Children with Huntington's Disease in the United States..  Movement disorders clinical practice.  4:682-688. 2017
• A predictive model to identify Parkinson disease from administrative claims data..  Neurology.  89:1448-1456. 2017
• Utilization of rehabilitation therapy services in Parkinson disease in the United States..  Neurology.  89:1162-1169. 2017
• National randomized controlled trial of virtual house calls for Parkinson disease..  Neurology.  89:1152-1161. 2017
• Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study..  Telemedicine and e-Health.  24:255-267. 2017
• Progressive rural-urban disparity in acute stroke care..  Neurology.  88:441-448. 2017
• Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1..  Journal of Parkinson's Disease.  7:117-127. 2017
• Hospital care for mental health and substance abuse conditions in Parkinson's disease..  Movement Disorders.  31:1810-1819. 2016
• Prevalence and Correlates of Anti-Parkinson Drug Use in a Nationally Representative Sample..  Movement disorders clinical practice.  4:335-341. 2016
• Patient safety events in hospital care of individuals with epilepsy..  Epilepsia.  57:1301-9. 2016
• Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease..  American journal of Alzheimer's disease and other dementias.  31:585-594. 2016
• Hospital care for mental health and substance abuse in children with epilepsy..  Epilepsy & behavior : E&B.  57:161-166. 2016
• Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease..  PLoS ONE.  11:-. 2016
• National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers..  Telemedicine and e-Health.  22:590-8. 2016
• Demographics, disparities, and outcomes in substernal goiters in the United States..  American Journal of Surgery.  211:703-9. 2016
• Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease.  American Journal of Alzheimer's Disease and other Dementias.  2016
• DRUM-PD: The Use of a Drum Circle to Improve the Symptoms and Signs of Parkinson's Disease (PD).  Movement Disorders Clinical Practice.  2016
• Erratum To: Virtual house calls for Parkinson disease (Connect.Parkinson): Study protocol for a randomized, controlled trial. Trials. 2014;15:465..  Trials.  2016
• Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease..  Movement disorders clinical practice.  3:257-267. 2015
• DRUM-PD: The use of a drum circle to improve the symptoms and signs of Parkinson's disease (PD)..  Movement disorders clinical practice.  3:243-249. 2015
• Using Administrative Data to Examine Health Disparities and Outcomes in Neurological Diseases of the Elderly..  Current Neurology and Neuroscience Reports.  15:-. 2015
• Nursing home and end-of-life care in Parkinson disease..  Neurology.  85:413-9. 2015
• Physician response to a medication alert system in inpatients with levodopa-treated diseases..  Neurology.  85:420-4. 2015
• Time to change the blind men and the elephant approach to Parkinson disease?.  Neurology.  85:190-6. 2015
• Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease.  Cochrane Database of Systematic Reviews.  2015
• Trends in inpatient antiparkinson drug use in the USA, 2001-2012.  European Journal of Clinical Pharmacology.  2015
• Feeding tube placement in stroke patients: urgent need for health services and outcomes research..  Neurology.  83:870-1. 2014
• Feeding tube placement in stroke patients: Urgent need for health services and outcomes research.  Neurology.  2014
• Relative mortality in U.S. medicare beneficiaries with parkinson disease and hip and pelvic fractures.  Journal of Bone and Joint Surgery - Series A.  2014
• Virtual house calls for Parkinson disease (Connect.Parkinson): Study protocol for a randomized, controlled trial.  Trials.  2014
• Disparities in deep brain stimulation surgery among insured elders with Parkinson disease..  Neurology.  82:163-71. 2013
• Bright light exposure reduces TH-positive dopamine neurons: Implications of light pollution in Parkinson's disease epidemiology.  Scientific Reports.  2013
• Caring for the majority.  Movement Disorders.  2013
• Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States.  Parkinsonism and Related Disorders.  2013
• Parkinson disease in the elderly adult..  Missouri medicine.  2013
• The coming crisis: Obtaining care for the growing burden of neurodegenerative conditions.  Neurology.  2013
• Neurologist-associated reduction in PD-related hospitalizations and health care expenditures.  Neurology.  2012
• Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.  Archives of Neurology.  2012
• Predictors of survival in patients with Parkinson disease.  Archives of Neurology.  2012
• Neurologist care in Parkinson disease: A utilization, outcomes, and survival study.  Neurology.  2011
• Conjugal Parkinsonism and Parkinson disease: A case series with environmental risk factor analysis.  Parkinsonism and Related Disorders.  2010
• Geographic and ethnic variation in Parkinson disease: A population-based study of us medicare beneficiaries.  Neuroepidemiology.  2010
• Metal emissions and urban incident parkinson disease: A community health study of medicare beneficiaries by using geographic information systems.  American Journal of Epidemiology.  2010
• High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy.  Developmental Medicine and Child Neurology.  2007